HUE054864T2 - In vitro módszer tüdõrák diagnosztizálására - Google Patents
In vitro módszer tüdõrák diagnosztizálásáraInfo
- Publication number
- HUE054864T2 HUE054864T2 HUE18703784A HUE18703784A HUE054864T2 HU E054864 T2 HUE054864 T2 HU E054864T2 HU E18703784 A HUE18703784 A HU E18703784A HU E18703784 A HUE18703784 A HU E18703784A HU E054864 T2 HUE054864 T2 HU E054864T2
- Authority
- HU
- Hungary
- Prior art keywords
- diagnosis
- lung cancer
- vitro method
- vitro
- lung
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382054.9A EP3361256A1 (en) | 2017-02-08 | 2017-02-08 | In vitro method for the diagnosis of lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE054864T2 true HUE054864T2 (hu) | 2021-10-28 |
Family
ID=58043996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE18703784A HUE054864T2 (hu) | 2017-02-08 | 2018-02-08 | In vitro módszer tüdõrák diagnosztizálására |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20200025765A1 (hu) |
| EP (2) | EP3361256A1 (hu) |
| CN (1) | CN110770584B (hu) |
| AU (1) | AU2018217372B2 (hu) |
| CA (1) | CA3052529A1 (hu) |
| DK (1) | DK3580567T3 (hu) |
| ES (1) | ES2880761T3 (hu) |
| HU (1) | HUE054864T2 (hu) |
| PL (1) | PL3580567T3 (hu) |
| PT (1) | PT3580567T (hu) |
| WO (1) | WO2018146232A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2603051B (en) | 2020-01-30 | 2023-04-26 | Prognomiq Inc | Lung biomarkers and methods of use thereof |
| JP2023545017A (ja) * | 2020-10-02 | 2023-10-26 | ボード オブ レジェンツ，ザ ユニバーシティ オブ テキサス システム | 肺がんの検出及び治療のための方法 |
| GB2607436A (en) * | 2021-03-31 | 2022-12-07 | Prognomiq Inc | Multi-omic assessment |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1635692T3 (da) * | 2003-06-13 | 2010-08-09 | Univ Pittsburgh | Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme |
| WO2013083847A2 (en) * | 2011-12-09 | 2013-06-13 | Institut Pasteur | Multiplex immuno screening assay |
| JP6082026B2 (ja) * | 2011-12-21 | 2017-02-15 | インテグレイティド ダイアグノスティクス，インコーポレイティド | 肺癌診断用の組成物、方法及びキット |
| WO2013143940A1 (en) * | 2012-03-29 | 2013-10-03 | Proyecto De Biomedicina Cima, S.L. | New lung cancer molecular markers |
-
2017
- 2017-02-08 EP EP17382054.9A patent/EP3361256A1/en not_active Withdrawn
-
2018
- 2018-02-08 ES ES18703784T patent/ES2880761T3/es active Active
- 2018-02-08 HU HUE18703784A patent/HUE054864T2/hu unknown
- 2018-02-08 PT PT187037841T patent/PT3580567T/pt unknown
- 2018-02-08 WO PCT/EP2018/053234 patent/WO2018146232A1/en unknown
- 2018-02-08 DK DK18703784.1T patent/DK3580567T3/da active
- 2018-02-08 US US16/483,714 patent/US20200025765A1/en active Pending
- 2018-02-08 EP EP18703784.1A patent/EP3580567B1/en active Active
- 2018-02-08 AU AU2018217372A patent/AU2018217372B2/en active Active
- 2018-02-08 CA CA3052529A patent/CA3052529A1/en active Pending
- 2018-02-08 CN CN201880020205.2A patent/CN110770584B/zh active Active
- 2018-02-08 PL PL18703784T patent/PL3580567T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018217372B2 (en) | 2024-01-25 |
| DK3580567T3 (da) | 2021-07-12 |
| EP3580567B1 (en) | 2021-04-07 |
| US20200025765A1 (en) | 2020-01-23 |
| PL3580567T3 (pl) | 2021-12-06 |
| AU2018217372A1 (en) | 2019-09-12 |
| EP3361256A1 (en) | 2018-08-15 |
| CA3052529A1 (en) | 2018-08-16 |
| CN110770584B (zh) | 2023-06-13 |
| WO2018146232A1 (en) | 2018-08-16 |
| ES2880761T3 (es) | 2021-11-25 |
| EP3580567A1 (en) | 2019-12-18 |
| PT3580567T (pt) | 2021-07-14 |
| CN110770584A (zh) | 2020-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1248773A1 (zh) | 用於癌症的治療和診斷方法 | |
| HK1250376A1 (zh) | 用於癌症的治療和診斷方法 | |
| IL261422A (en) | Therapeutic and diagnostic methods for cancer | |
| EP3149210A4 (en) | Method and systems for lung cancer diagnosis | |
| IL250507B (en) | Anti-ck8 antibodies for use in cancer treatment | |
| EP3298145A4 (en) | Method of diagnosis of breast cancer | |
| ZA202000851B (en) | Antibodies useful in cancer diagnosis | |
| PL3580567T3 (pl) | Metoda in vitro w diagnostyce raka płuc | |
| HK1243434A1 (zh) | Igf-1r抗體及其診斷癌症的用途 | |
| PT3298165T (pt) | Método e kit para diagnóstico de cancro colorretal | |
| HK1248730A1 (zh) | Igf-1r抗體及其用於癌症診斷的用途 | |
| SI3794148T1 (sl) | Postopki za diagnostiko anevrizme ali raka | |
| ZA202107946B (en) | Methods for the diagnosis of lung cancer | |
| HUP1800440A2 (hu) | In vitro eljárás rosszindulatú állapotok diagnosztizálására |